Items Tagged ‘Rintega’

July 1st, 2015

Rintega® Improves Survival in Patients with Glioblastoma Multiforme


The immunotherapy drug Rintega® (rindopepimut) appears to improve survival among patients with relapsed glioblastoma multiforme (GBM) brain cancer. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago, Illinois) and published in the Journal of Clinical Oncology. Glioblastoma multiforme is one of the most common and […]

View full entry

Tags: avastin, bevacizumab, Brain Cancer, clinical trial, EGFRvIII, gbm, General Brain Cancer, glioblastoma multiforme brain cancer, News, rindopepimut, Rintega